Myocarditis or pericarditis after BNT162b2 vaccination in youth in Ontario
JAMA Pediatrics
Published 2023-02-27 · Original archive entry · Explore research explainers
About The Study: The results of this study of 1.65 million doses of BNT162b2 (Comirnaty [Pfizer-BioNTech]) vaccinations among adolescents in Ontario, Canada, suggest that there was variation in the reported incidence of myocarditis or pericarditis. However, the risk of these events after vaccination remains very rare and should be considered in relation to the benefits of COVID-19 vaccination.
Authors: Sarah E. Wilson, M.D., M.Sc., of Public Health Ontario in Toronto, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamapediatrics.2022.6166)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2022.6166?guestAccessKey=76aee0a3-0ad8-44c4-b144-3cf2ca162e67&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=022723
END
Authors: Sarah E. Wilson, M.D., M.Sc., of Public Health Ontario in Toronto, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamapediatrics.2022.6166)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2022.6166?guestAccessKey=76aee0a3-0ad8-44c4-b144-3cf2ca162e67&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=022723
END